Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 2, February

Editorial [Hot Topic: Nano Drugs: Novel Agents for Cancer Chemo-Therapy (Guest Editor: Imran Ali)]

Volume:11   Issue: 2
Pp: 130-130
Imran Ali
DOI: 10.2174/156800911794328466
Published on: 01 March, 2012

Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives

Volume:11   Issue: 2
Pp: 131-134
I. Ali
DOI: 10.2174/156800911794328457
Published on: 01 March, 2012

Advances in Nano Drugs for Cancer Chemotherapy

Volume:11   Issue: 2
Pp: 135-146
I. Ali, Rahis-Uddin, K. Salim, M. A. Rather, W. A. Wani and A. Haque
DOI: 10.2174/156800911794328493
Published on: 01 March, 2012

Molecular Targeting of Liposomal Nano-Particles to Lymphatic System

Volume:11   Issue: 2
Pp: 147-155
Nguyen-Van Cuong and Ming-Fa Hsieh
DOI: 10.2174/156800911794328439
Published on: 01 March, 2012

Silica Nanoparticles as Promising Drug/Gene Delivery Carriers and Fluorescent Nano-Probes: Recent Advances

Volume:11   Issue: 2
Pp: 156-163
Y. Liu, C. Lou, H. Yang, M. Shi and H. Miyoshi
DOI: 10.2174/156800911794328411
Published on: 01 March, 2012

Current Major Cancer Targets for Nanoparticle Systems

Volume:11   Issue: 2
Pp: 164-183
D. Wesselinova
DOI: 10.2174/156800911794328484
Published on: 01 March, 2012

Magnetic Iron Oxide Nanoparticles for Tumor-Targeted Therapy

Volume:11   Issue: 2
Pp: 184-189
B. Chen, W. Wu and X. Wang
DOI: 10.2174/156800911794328475
Published on: 01 March, 2012

PI-3-Kinase Inhibitors in Colorectal Cancer

Volume:11   Issue: 2
Pp: 190-198
N. T. Ihle, G. Powis and S. Kopetz
DOI: 10.2174/156800911794328448
Published on: 01 March, 2012

Epigenetic Regulation of Gene Expression as an Anticancer Drug Target

Volume:11   Issue: 2
Pp: 199-212
L. R. Ferguson, A. L. Tatham, Z. Lin and W. A. Denny
DOI: 10.2174/156800911794328510
Published on: 01 March, 2012

The Gamma Catenin/CBP Complex Maintains Survivin Transcription in β-catenin Deficient/Depleted Cancer Cells

Volume:11   Issue: 2
Pp: 213-225
Y.-M. Kim, H. Ma, V. G. Oehler, E. J. Gang, C. Nguyen, D. Masiello, H. Liu, Y. Zhao, J. Radich and M. Kahn
DOI: 10.2174/156800911794328420
Published on: 01 March, 2012

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

Volume:11   Issue: 2
Pp: 226-235
M. Montopoli, M. Bellanda, F. Lonardoni, E. Ragazzi, P. Dorigo, G. Froldi, S. Mammi and L. Caparrotta
DOI: 10.2174/156800911794328501
Published on: 01 March, 2012